202 related articles for article (PubMed ID: 11943385)
1. Loading anticancer drugs into HDL as well as LDL has little affect on properties of complexes and enhances cytotoxicity to human carcinoma cells.
Kader A; Pater A
J Control Release; 2002 Apr; 80(1-3):29-44. PubMed ID: 11943385
[TBL] [Abstract][Full Text] [Related]
2. Natural low- and high-density lipoproteins as mighty bio-nanocarriers for anticancer drug delivery.
Mahmoudian M; Salatin S; Khosroushahi AY
Cancer Chemother Pharmacol; 2018 Sep; 82(3):371-382. PubMed ID: 29915981
[TBL] [Abstract][Full Text] [Related]
3. Drug targeting using low density lipoprotein (LDL): physicochemical factors affecting drug loading into LDL particles.
Kader A; Davis PJ; Kara M; Liu H
J Control Release; 1998 Nov; 55(2-3):231-43. PubMed ID: 9795069
[TBL] [Abstract][Full Text] [Related]
4. [Recent development of natural and reconstituted lipoprotein based nano drug delivery vehicles].
Xu Y; Jin XF; Ping QN; Liu HF; Chen M; Xu XM
Yao Xue Xue Bao; 2014 Jan; 49(1):23-9. PubMed ID: 24783501
[TBL] [Abstract][Full Text] [Related]
5. Encapsulation of anticancer drug curcumin and co-loading with photosensitizer hypericin into lipoproteins investigated by fluorescence resonance energy transfer.
Jutkova A; Chorvat D; Miskovsky P; Jancura D; Datta S
Int J Pharm; 2019 Jun; 564():369-378. PubMed ID: 31022501
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein-associated alpha-tocopheryl-succinate inhibits cell growth and induces apoptosis in human MCF-7 and HBL-100 breast cancer cells.
Pussinen PJ; Lindner H; Glatter O; Reicher H; Kostner GM; Wintersperger A; Malle E; Sattler W
Biochim Biophys Acta; 2000 May; 1485(2-3):129-44. PubMed ID: 10832094
[TBL] [Abstract][Full Text] [Related]
7. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
8. Low density lipoprotein as a targeted carrier for doxorubicin in nude mice bearing human hepatoma HepG2 cells.
Chu AC; Tsang SY; Lo EH; Fung KP
Life Sci; 2001 Dec; 70(5):591-601. PubMed ID: 11811903
[TBL] [Abstract][Full Text] [Related]
9. Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs.
Lacko AG; Nair M; Prokai L; McConathy WJ
Expert Opin Drug Deliv; 2007 Nov; 4(6):665-75. PubMed ID: 17970668
[TBL] [Abstract][Full Text] [Related]
10. Delivery of hydrophilic drug doxorubicin hydrochloride-targeted liver using apoAI as carrier.
Yuan Y; Wang W; Wang B; Zhu H; Zhang B; Feng M
J Drug Target; 2013 May; 21(4):367-74. PubMed ID: 23600747
[TBL] [Abstract][Full Text] [Related]
11. Structural characterisation of nucleoside loaded low density lipoprotein as a main criterion for the applicability as drug delivery system.
Hammel M; Laggner P; Prassl R
Chem Phys Lipids; 2003 Apr; 123(2):193-207. PubMed ID: 12691852
[TBL] [Abstract][Full Text] [Related]
12. Circumvention of multidrug resistance and reduction of cardiotoxicity of doxorubicin in vivo by coupling it with low density lipoprotein.
Lo EH; Ooi VE; Fung KP
Life Sci; 2002 Dec; 72(6):677-87. PubMed ID: 12467908
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agents.
Glickson JD; Lund-Katz S; Zhou R; Choi H; Chen IW; Li H; Corbin I; Popov AV; Cao W; Song L; Qi C; Marotta D; Nelson DS; Chen J; Chance B; Zheng G
Mol Imaging; 2008; 7(2):101-10. PubMed ID: 18706292
[TBL] [Abstract][Full Text] [Related]
14. Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting.
Rensen PC; de Vrueh RL; Kuiper J; Bijsterbosch MK; Biessen EA; van Berkel TJ
Adv Drug Deliv Rev; 2001 Apr; 47(2-3):251-76. PubMed ID: 11311995
[TBL] [Abstract][Full Text] [Related]
15. Benefits of hypericin transport and delivery by low- and high-density lipoproteins to cancer cells: From in vitro to ex ovo.
Lenkavska L; Blascakova L; Jurasekova Z; Macajova M; Bilcik B; Cavarga I; Miskovsky P; Huntosova V
Photodiagnosis Photodyn Ther; 2019 Mar; 25():214-224. PubMed ID: 30597213
[TBL] [Abstract][Full Text] [Related]
16. A high-density lipoprotein-mediated drug delivery system.
Mo ZC; Ren K; Liu X; Tang ZL; Yi GH
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):132-147. PubMed ID: 27208399
[TBL] [Abstract][Full Text] [Related]
17. Synthetic lipoprotein as nano-material vehicle in the targeted drug delivery.
Zhang X; Huang G
Drug Deliv; 2017 Dec; 24(sup1):16-21. PubMed ID: 29069931
[TBL] [Abstract][Full Text] [Related]
18. Green-step assembly of low density lipoprotein/sodium carboxymethyl cellulose nanogels for facile loading and pH-dependent release of doxorubicin.
He L; Liang H; Lin L; Shah BR; Li Y; Chen Y; Li B
Colloids Surf B Biointerfaces; 2015 Feb; 126():288-96. PubMed ID: 25576811
[TBL] [Abstract][Full Text] [Related]
19. Preparation of drug-low density lipoprotein complexes for delivery of antitumoral drugs via the low density lipoprotein pathway.
Lundberg B
Cancer Res; 1987 Aug; 47(15):4105-8. PubMed ID: 3607752
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells.
Rui M; Qu Y; Gao T; Ge Y; Feng C; Xu X
Int J Nanomedicine; 2017; 12():217-237. PubMed ID: 28115844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
